TITLE

Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells

AUTHOR(S)
Alarifi, Saud; Ali, Daoud; Alkahtani, Saad; Siddiqui, Maqsood A.; Ali, Bahy A.
PUB. DATE
February 2013
SOURCE
OncoTargets & Therapy;2013, Vol. 6, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Arsenic is a ubiquitous environmental toxicant, and abnormalities of the skin, lung, kidney, and liver are the most common outcomes of long-term arsenic exposure. This study was designed to investigate the possible mechanisms of genotoxicity induced by arsenic trioxide in human hepatocellular carcinoma cells. Methods and results: A mild cytotoxic response of arsenic trioxide was observed in human hepatocellular carcinoma cells, as evident by (3-(4,5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) and lactate dehydrogenase assays after 24 and 48 hours of exposure. Arsenic trioxide elicited a significant (P , 0.01) reduction in glutathione (15.67% and 26.52%), with a concomitant increase in malondialdehyde level (67.80% and 72.25%; P , 0.01), superoxide dismutase (76.42% and 81.09%; P , 0.01), catalase (73.33% and 76.47%; P , 0.01), and reactive oxygen species generation (44.04% and 56.14%; P , 0.01) after 24 and 48 hours of exposure, respectively. Statistically significant (P , 0.01) induction of DNA damage was observed by the comet assay in cells exposed to arsenic trioxide. It was also observed that apoptosis occurred through activation of caspase-3 and phosphatidylserine externalization in human hepatocellular carcinoma cells exposed to arsenic trioxide. Conclusion: The results demonstrate that arsenic trioxide induces apoptosis and genotoxicity in human hepatocellular carcinoma cells through reactive oxygen species and oxidative sress.
ACCESSION #
87991702

 

Related Articles

  • Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell. Wang, Zheng; Li, Pei; Xu, Qinhong; Xu, Jun; Li, Xuqi; Zhang, Xufeng; Ma, Qingyong; Wu, Zheng // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Hepatocellular carcinoma is one of the most common malignant neoplasms in the world and is the main cause of death in patients with liver cirrhosis. Surgical intervention is not suitable for majority of hepatocellular carcinoma. Investigation of the effective targeting to the tumor cells is...

  • Sorafenib Tablets (Nexavar). Elliott, William T.; Chan, James // Internal Medicine Alert;12/29/2007, Vol. 29 Issue 24, p190 

    The article presents an update about Sorafenib tablets, which has been approved by the U.S. Food and Drugs Administration (FDA) for the treatment of inoperable hepatocellular cancer.

  • Sorafenib.  // Reactions Weekly;12/11/2010, Issue 1331, p29 

    The article describes the case of a 64-year-old man with metastatic liver cancer who experienced liver dysfuction following sorafenib treatment.

  • Nexavar Improves Cancer Survival.  // Clarendon Enterprise (TX);7/5/2007, Vol. 18 Issue 29, p12 

    The article presents information on the antineoplastic agent sorafenib against liver cancer.

  • Lapatinib only benefited subgroup of patients with hepatocellular carcinomas. Adams, Stacey L.; DiMarcantonio, Tina; Haigh, Christen; Harris, Jason // Hem/Onc Today;10/25/2009, Vol. 10 Issue 20, p27 

    The article discusses research on the efficacy and tolerability of lapatinib administered orally to patients with hepatocellular carcinomas, conducted by T. Bekali-Saab et al, published in a 2009 issue of the journal "Clinical Cancer Research."

  • Basic Mechanisms of Arsenic Trioxide (ATO)- Induced Apoptosis in Human Leukemia (HL-60) Cells. Yedjou, Clement; Tchounwou, Paul; Jenkins, John; McMurray, Robert // Journal of Hematology & Oncology;2010, Vol. 3, p28 

    Background: Acute promyelocytic leukemia (APL) is a blood cancer that affects people of all ages and strikes about 1,500 patients in the United States each year. The standard treatment of APL has been based on the combined administration of all-trans retinoic acid and chemotherapy including...

  • A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Dalhoff, K; Dancey, J; Astrup, L; Skovsgaard, T; Hamberg, K J; Lofts, F J; Rosmorduc, O; Erlinger, S; Bach Hansen, J; Steward, W P; Skov, T; Burcharth, F; Evans, T R J // British Journal of Cancer;7/21/2003, Vol. 89 Issue 2, p252 

    Hepatocellular carcinoma (HCC) is a common malignant tumour, which has a poor prognosis. Surgical resection can be curative but most patients are inoperable and most chemotherapy agents have minimal activity in this disease. Seocalcitol, a vitamin D analogue, induces differentiation and inhibits...

  • CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens. Furuta, Junpei; Inozume, Takashi; Harada, Kazutoshi; Shimada, Shinji // Journal of Investigative Dermatology;May2014, Vol. 134 Issue 5, p1369 

    IFN-γ released from cytotoxic T lymphocytes (CTLs) during the effector phase is essential for rejecting bulky melanoma tumors. In contrast, IFN-γ is known to induce certain immunosuppressive factors in tumor cells such as programmed cell death 1 ligand 1 (PD-L1). In this study, we have...

  • Nitric oxide mitigates arsenic-induced oxidative stress and genotoxicity in Vicia faba L. Shukla, Pratiksha; Singh, A. // Environmental Science & Pollution Research;Sep2015, Vol. 22 Issue 18, p13881 

    The protective effects of nitric oxide (NO) against arsenic (As)-induced structural disturbances in Vicia faba have been investigated. As treatment (0.25, 0.50, and 1 mM) resulted in a declined growth of V. faba seedlings. Arsenic treatment stimulates the activity of SOD and CAT while the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics